A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is ...

Daiichi Sankyo used the National Cherry Blossom Festival in Washington, D.C. as a platform to raise awareness about its oncology goals.

A brave gran battling breast cancer for more than a decade is facing the heart-wrenching prospect of moving hundreds of miles to Scotland for access to a drug that could save her life. Beverley Angell ...

A grandma who has fought breast cancer for more than a decade may be forced to move to Scotland to access a lifesaving drug. Beverley Angell, 68, is having to consider moving 467 miles from London to ...

Beverley Angell, 68, is having to consider moving 467 miles from London to Scotland as the drug she needs - Enhurtu for HER2-low - is not available on the NHS in England. Privately it would cost ...

Daiichi Sankyo Company, Limited leads in ADC tech with Enhertu, strong partnerships, revenue growth, and global market leadership. Click to know more on why DSNKY is a Buy.

EU approves expanded use of ABBV's Rinvoq and AZN's Imfinzi and Enhertu. NVS set to invest $23B to boost U.S. manufacturing.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...